<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"ACL":1,
"ALK rearrangement":1,
"smoking history":1,
"unselected Caucasian population":1,
"Epidermal growth factor receptor":2,
"Epithelial-to-mesenchymal transition":2,
"Hepatocellular carcinoma":5,
"Hepatocellular carcinoma related protein 1":1,
"Breast cancer":24,
"DNA methylation":5,
"Methyl donors":1,
"Apoptosis":6,
"Invasion":6,
"Osteosarcoma":1,
"Proliferation":13,
"Pyruvate kinase type M2":1,
"Tumor orthotopic model":1,
"Immune-related adverse events":2,
"Interleukin-2":1,
"Melanoma":2,
"PROCLAIMSM":1,
"Renal cell carcinoma":2,
"Survival":9,
"Prox-1":1,
"cat":2,
"immunohistochemistry":9,
"lymphendothelium":1,
"plexiform vasculopathy":1,
"Elasticity imaging techniques":1,
"Shear wave":1,
"Thyroid cancer, papillary":2,
"Thyroid nodule":36,
"Autistic Disorder":1,
"Caries":1,
"Fluoride":1,
"Growth and Development":1,
"Mental Retardation":1,
"Thyroid Gland":9,
"Carcinoma de tiroides":1,
"Carcinoma folicular":1,
"Carcinoma papilar":1,
"Follicular carcinoma":4,
"Papillary carcinoma":7,
"Thyroid carcinoma":25,
"Thyroidectomy":19,
"Tiroidectomía":1,
"Robotic":1,
"cervical lymphadenectomy":1,
"neck dissection":3,
"papillary thyroid carcinoma":60,
"squamous cell carcinoma":3,
"Diagnosis":10,
"Malignancy risk":2,
"Molecular marker":1,
"Thyroid nodules":15,
"Ultrasound":13,
"Lateral lymph node metastasis":1,
"Papillary thyroid microcarcinoma":6,
"Predictors":1,
"Skip metastasis":2,
"glycogen":1,
"long noncoding RNA":1,
"migration":5,
"synthase kinase 3β":1,
"Breast neoplasms":3,
"Care delay":1,
"Patient delay":1,
"Prognosis":25,
"Related factors":1,
"NIS":2,
"differentiation":3,
"drug resistance":1,
"targeted therapy":6,
"Afirma":2,
"TIRADS":3,
"endocrine surgery":1,
"indeterminate nodules":2,
"interobserver variability":1,
"thyroid":27,
"CTLA4":1,
"Cancer treatment":1,
"Endocrine side effects":1,
"Hyponatremia":1,
"Hypophysitis":2,
"Immune checkpoint inhibitors":1,
"PD1/PD1-L":1,
"Thyroid diseases":1,
"SphK2":1,
"lncRNA LINC00460":1,
"miR-613":1,
"elastosonography":1,
"shear wave elastography":3,
"thyroid cancer":83,
"Apocrine papillary lesion":1,
"Encapsulated apocrine papillary carcinoma":1,
"Papilloma with DCIS":1,
"cholecystokinin-2 receptor":1,
"minigastrin":1,
"molecular imaging":2,
"radiometals":1,
"targeted radiotherapy":1,
"Thyroid papillary microcarcinoma":1,
"thyroid lobo-isthmectomy":1,
"total thyroidectomy":4,
"Carcinoma":5,
"Clinicopathology":1,
"Hashimoto thyreoiditis":1,
"Molecular pathology":1,
"Adipofascial flap":1,
"Oncoplastic breast surgery":1,
"Slim body":1,
"Volume replacement":1,
"Cytology":12,
"Location":1,
"Neoplasms":4,
"Thyroid Imaging, Reporting, and Data System":1,
"2-stage":1,
"posterior tibial artery perforator flap":1,
"tracheal invasion":1,
"tracheal reconstruction":3,
"LY294002":1,
"Lamc1":1,
"PKM2":5,
"PTEN/AKT pathway":1,
"si-p110 PI3K":1,
"TSH":2,
"glucose":1,
"papillary thyroid cancer":24,
"thyroid hormone":2,
"thyroid-stimulating hormone":1,
"anterior chest approach":1,
"endoscopic thyroidectomy":2,
"lateral neck dissection":2,
"needle assisted":1,
"Ablation techniques":2,
"High-intensity focused ultrasound ablation":1,
"Interventional ultrasonography":1,
"Nodular goiter":1,
"Ultrasound imaging":1,
"anaplastic":3,
"cancer":16,
"cancer trial":1,
"chemotherapy":4,
"clinical trial":3,
"clinicaltrials gov":1,
"follicular":1,
"head and neck cancer":4,
"medullary":2,
"papillary":1,
"pubmed gov":1,
"radiation therapy":1,
"radioactive iodine":3,
"surgery":12,
"thyroid malignancy":2,
"cost effectiveness":1,
"differentiated thyroid cancer":9,
"extent of surgery":1,
"healthcare cost":1,
"Bethesda system":5,
"fine-needle aspiration biopsy":1,
"prevalence":5,
"test characteristics":1,
"calcitonin reference range":1,
"electrochemiluminescence immunoassay":1,
"medullary thyroid cancer":4,
"multiple endocrine neoplasia type 2":2,
"AUS/FLUS":1,
"LncRNA":1,
"PTC":4,
"UNC5B-AS1":1,
"Evaluation":1,
"Immunoassay":1,
"Isotope-diluted liquid chromatography tandem mass spectrometry":1,
"Performance":1,
"Thyroxine":1,
"Ultrasound diagnosis":1,
"epithelial-mesenchymal transition":4,
"junctional adhesion molecule A":1,
"motility":3,
"differentiated thyroid carcinoma":9,
"minirecovery":1,
"thyroglobulin":4,
"thyroglobulin antibodies":1,
"body mass index":1,
"extrathyroidal invasion":1,
"locoregional recurrence":1,
"vascular invasion":1,
"HK2":1,
"miR-143":1,
"microPET/CT":1,
"poorly differentiated thyroid carcinoma":2,
"visual evaluation":1,
"lymph nodes":3,
"lymphatic metastasis":3,
"meta-analysis":10,
"thyroid neoplasms":17,
"Atherosclerosis":1,
"Inflammation":2,
"Positron emission tomography (PET)":1,
"TSH suppression":2,
"Thyroid disease":6,
"B-mode grayscale ultrasound":1,
"fine-needle aspiration cytology":3,
"thyroid nodule size":1,
"131-radioiodine therapy":1,
"Levo-thyroxine withdrawal":1,
"Radioiodine side effects":1,
"rhTSH stimulation":1,
"circulating microRNAs":1,
"miR-146":1,
"miR-221":1,
"miR-222":1,
"microRNAs":1,
"prognostic":1,
"Benign nodules":2,
"Clinical effect":1,
"Microwave ablation":2,
"Stress response":1,
"Magnetic tracer":1,
"Sentinel lymph node biopsy":1,
"Superparamagnetic iron oxide (SPIO)":1,
"Completion thyroidectomy":3,
"Complications":1,
"Hypocalcaemia":1,
"Oncological benefits":1,
"131I":1,
"1ng/mL":1,
"Pre-ablation stimulated thyroglobulin":1,
"AGK-BRAF":1,
"BRAF V600E":2,
"pediatric thyroid cancer":2,
"RET":6,
"Ser891Ala":1,
"founder effect":1,
"prophylactic thyroidectomy":2,
"Bethesda system for reporting thyroid cytopathology-BSRTC":1,
"Fine needle aspiration-FNA":1,
"Follicular neoplasm with papillary like nuclear features-NIFTP":1,
"Risk of malignancy-ROM":1,
"Early detection":1,
"GC/MS":1,
"LC/MS":1,
"Metabolomics":1,
"NMR":1,
"Thyroid cancer diagnosis":1,
"CD47":1,
"anaplastic thyroid carcinoma":5,
"immune checkpoints":3,
"phagocytosis":1,
"programmed cell death 1":1,
"tumor-associated macrophages":1,
"fine-needle aspiration":11,
"occult lateral neck lymph node metastasis":1,
"pathological features":1,
"High risk":1,
"Radioiodine ablation":1,
"Retrospective study":1,
"candidate genes":1,
"familial non-medullary thyroid carcinoma":1,
"germline predisposition variants":1,
"rare variants":1,
"whole-genome sequencing":1,
"Differentially expressed genes (DEGs)":1,
"Papillary thyroid carcinoma (PTC)":6,
"Pathological stage":1,
"Weighted gene co-expression network analysis (WGCNA)":1,
"Colorectal cancer":4,
"Gastric cancer":5,
"Lipidomics":1,
"Liver cancer":1,
"Lung cancer":4,
"Plasma":1,
"UHPLC-ESI-MS/MS":1,
"hyperparathyroidism":3,
"lncRNAs":1,
"parathyroid tumors":1,
"Variance-Reduction statistic":1,
"automatic detection":1,
"nodule boundary":1,
"ultrasound images":1,
"RNA interference":1,
"Wnt/β-catenin signaling":2,
"breast carcinoma":1,
"minichromosome maintenance protein 10":1,
"Cancer vaccines":1,
"Carbohydrate":1,
"Immunotherapy":8,
"Tumor-associated carbohydrate antigens":1,
"elasticity":1,
"ultrasonography":9,
"Dihydroartemisinin":1,
"Esophageal cancer":2,
"Glycolysis":2,
"Pyruvate kinase M2":1,
"Efficacy":2,
"Sorafenib":4,
"Thyroid neoplasm":6,
"Tumor doubling time":1,
"epidemiology":2,
"incidence":7,
"pediatrics":2,
"registries":1,
"Medullary carcinoma":2,
"Radiotherapy":2,
"Systematic review":4,
"disability":1,
"neck pain":1,
"trigger points":1,
"I treatment":1,
"bone metastases":2,
"multimodal treatment":1,
"overall survival":2,
"prognostic factors":2,
"BRAFV600E mutation":3,
"Sanger sequencing":2,
"ddPCR":1,
"extranodal extension":1,
"recurrence":11,
"risk-stratification system":1,
"BRAF":7,
"RAS":4,
"TERT":4,
"mutation":5,
"radioactive iodine refractory (RAIR)":1,
"hyperthyroidism":5,
"thyrotoxicosis":1,
"biomarkers":2,
"demethylating drugs":1,
"global hypomethylation":1,
"Cancer staging":1,
"Vitamin D":2,
"active surveillance":4,
"quality of life":4,
"circular RNA":3,
"malignant cancer":1,
"receiver operating characteristic":1,
"serum biomarker":1,
"CDK6":1,
"LINC00511":1,
"Paclitaxel cytotoxicity":1,
"miR-29c":1,
"Graves’ disease":2,
"autoantibody":1,
"decoy effect":1,
"exosome":1,
"thyrotropin receptor":1,
"Kidney Neoplasms":1,
"Contrast-enhanced ultrasound":2,
"Gray-scale ultrasound":1,
"Thyroid Imaging Reporting and Data System":2,
"TI-RADS":4,
"medullary thyroid carcinoma (MTC)":1,
"modified":1,
"CFL1":1,
"LIMK1":1,
"Progression":3,
"miR-128-3p":1,
"Single nucleotide polymorphisms":1,
"UGT2B7":1,
"EZH2":1,
"H3K27":1,
"miR-124/506":1,
"HOXB8":1,
"MIF-AS1":1,
"ceRNA":3,
"miR-1249-3p":1,
"Akt":2,
"Evodiamine":1,
"HDAC inhibitor":1,
"Synergism":1,
"Classic type papillary thyroid microcarcinoma":1,
"Follicular variant of papillary thyroid microcarcinoma":1,
"Risk factor":3,
"Thyroid microcarcinoma smaller than 5 mm":1,
"Environmental exposure":1,
"Heavy metals":1,
"Urine":1,
"KIF5B–RET":1,
"cancer biology":1,
"cancer therapy":1,
"inhibitor":1,
"mutant":1,
"structural biology":1,
"tyrosine-protein kinase (tyrosine kinase)":1,
"METTL7B":1,
"metastasis":16,
"Biomarker":6,
"COL1A1":1,
"Extracellular matrix":1,
"Gene expression":1,
"accelerated aging":1,
"network analysis":1,
"pan-cancer":1,
"Detection":1,
"Insulin resistance":3,
"Nodules":1,
"Obesity":3,
"Endoscopy":2,
"Minimally invasive surgical procedure":1,
"TOETVA":2,
"Transoral":1,
"Transoral thyroidectomy":1,
"aggressive variants":1,
"anaplastic carcinoma":1,
"fine needle aspiration cytology":6,
"personalized medicine":3,
"poorly differentiated carcinoma":1,
"Biopsy":6,
"malignancy":5,
"positron emission tomography-computerized tomography":1,
"thyroid incidentaloma":1,
"Adenocarcinoma lung":1,
"nonthyroidal thyroid metastasis":1,
"papillary carcinoma thyroid":1,
"thyroid metastasis":1,
"Diffuse large B-cell lymphoma":1,
"MALT lymphoma":1,
"extranodal":1,
"lymphoma":2,
"marginal zone lymphoma":1,
"Health-care costs":1,
"retrospective cohort studies":1,
"Lateral lymph node":1,
"thyroid papillary carcinoma":2,
"giant cells":1,
"osteoclasts":1,
"Bilaterality":1,
"Multifocality":1,
"collimators":1,
"parallel-hole collimators":1,
"radioiodine":3,
"scintigraphy":3,
"whole-body imaging":1,
"“pin-hole”":1,
"Fine needle aspiration biopsy":2,
"Lymph node metastasis":7,
"Papillary microcarcinoma":1,
"Proteomics":3,
"genetic predisposition":1,
"genetic sequencing":1,
"polycystic kidney disease":1,
"YWHAZ":1,
"14-3-3 zeta":1,
"gastric carcinoma":1,
"miR-375":1,
"dose constraint":1,
"supraclavicular radiotherapy":1,
"thyroid gland dose":1,
"clinicopathological features":3,
"epidemiological features":1,
"basal subtype":1,
"matrix-producing carcinoma":1,
"neoadjuvant chemotherapy":1,
"triple-negative":1,
"Fistula":1,
"angiogenesis inhibitor":1,
"bleeding":1,
"lenvatinib":11,
"LINC00982":1,
"PI3K/AKT":1,
"cell proliferation":1,
"Adenomas":1,
"Endocrinology":2,
"Endoscopic endonasal surgery":1,
"Multidisciplinary team":1,
"Pituitary/hypothalamus":1,
"Radiation oncology":1,
"Targeted drugs":1,
"IGF axis":1,
"therapeutic approach":1,
"anaplastic thyroid cancer":7,
"clinical trials":3,
"precision medicine":1,
"AHP methodology":1,
"Health technology assessment":1,
"Likert scale":1,
"Multicriteria decision problems":1,
"Prophylactic central neck dissection":1,
"Boxer":1,
"Cervical mass":1,
"Thyroid cyst":1,
"Thyroid cystic adenoma":1,
"Advanced gastric cancer":1,
"Chemotherapy response":1,
"Neutrophil–lymphocyte ratio":1,
"Platelet–lymphocyte ratio":1,
"G548V":1,
"MEN 2":1,
"MTC":1,
"Medullary thyroid carcinoma":14,
"Retrocopy":1,
"Second hit":1,
"Complication rates":1,
"Computed tomography":2,
"Disease-free survival":1,
"Invasive mucinous adenocarcinoma":1,
"Case report":5,
"Histological findings":1,
"Multiple metastases":1,
"Pancreatic neuroendocrine tumors":1,
"Rare metastatic localization":1,
"Surgical treatment":1,
"ADC":1,
"DWI":1,
"MRI":1,
"Region of interest":1,
"Cancer incidence":1,
"Human cancers":2,
"Sexual dimorphism":1,
"BRAF V600E mutation":1,
"Co-mutations":1,
"NRAS mutation":1,
"TERT mutation":1,
"DEGs":1,
"KEGG pathway":1,
"PPI network":1,
"bioinformatic analysis":1,
"miRNA-gene network":1,
"MicroRNA":3,
"Plasma samples":1,
"calcium and bone":2,
"pituitary disorders":2,
"Association":1,
"Primary hyperparathyroidism":2,
"Secondary hyperparathyroidism":2,
"effect modification by BMI status":1,
"mitochondrial DNA copy number":1,
"oxidative DNA damage":1,
"two-stage case-control study":1,
"Calcitonin":5,
"Carcinoma, medullary":1,
"Cost-benefit analsis":1,
"prostate":1,
"GATAD2A":1,
"Hsa_circ_0058124":1,
"NOTCH3":1,
"Hypercalcitoninemia":1,
"Parathyroid surgery":1,
"Renal insufficiency":1,
"genetics":2,
"forearm autotransplantation":1,
"hyperparathyroidism, secondary":1,
"parathyroidectomy":1,
"lateral neck transfer":1,
"parapharyngeal transfer":1,
"AMPK":2,
"Autophagy":2,
"HMGB1":1,
"mTOR":2,
"ACE27":1,
"ASA":1,
"advanced age":1,
"elderly":1,
"free flaps":1,
"medical complications":1,
"oral cancer":1,
"surgical complications":1,
"Bladder cancer":2,
"EGFR":1,
"TRIP13":2,
"Tumorigenesis":2,
"Bone and bones":1,
"Leiomyosarcoma":1,
"Liver":1,
"Spine":1,
"multiple primary":1,
"8505C cells":1,
"BCPAP cells":1,
"DU145 cells":1,
"HL-60 cells":1,
"LNCaP cells":1,
"cancer gene software":1,
"kidney cancer":1,
"prostate cancer":2,
"polymorphisms":1,
"Refractory psoriasis":1,
"Sarcoid-like reaction":1,
"Sarcoidosis":1,
"Ustekinumab":1,
"Poria cocos":1,
"inhibit SATB1 expression":1,
"inhibit migration of human breast cancer MDA-MB-231 cells":1,
"polysaccharide":1,
"sulfuric acid derivatization":1,
"SFRP1":1,
"miR-509-5p":1,
"Cancer research":1,
"Canis familiaris":1,
"Oncogene protein HER-2":1,
"Oncology":3,
"Pathology":2,
"Veterinary medicine":1,
"Central nervous system":1,
"metastatic":1,
"primary":1,
"tumors":1,
"Milan classification":1,
"histopathology":6,
"salivary glands":1,
"Auto-immune disease":1,
"Oral lichen planus":1,
"Thyroid gland diseases":1,
"Intraparotid node metastasis":1,
"Parotid cancer":1,
"Parotid squamous cell carcinoma":1,
"Prognosis analysis":1,
"Solitary thyroid nodule":1,
"BRAFV600E":2,
"CDK4/6":1,
"clonal evolution":1,
"copy number variations":1,
"microenvironment":1,
"palbociclib":1,
"ultra-precision therapy":1,
"vemurafenib":1,
"Angiopoietin-like 2":1,
"CK19":1,
"TROP-2":1,
"North India":1,
"lung":1,
"NRAS":1,
"TERT promoter":1,
"THY 3":1,
"follicular thyroid carcinoma":7,
"indeterminate lesions":1,
"skin metastasis":1,
"Adrenal gland":1,
"Adrenal neoplasms":1,
"Laparoscopic surgery":1,
"Laparoscopy":1,
"Uterine cancer":1,
"Epstein–Barr Virus Nuclear Antigens":1,
"Familial Hemophagocytic Lymphohistiocytosis, Lymphoma, Perforin Gene Mutation":1,
"Bethesda":2,
"Children":2,
"IASLC/ATS/ERS guidelines":1,
"nomenclature":1,
"small biopsies":1,
"three-step approach":1,
"Autism spectrum disorder":1,
"isolation":1,
"lung metastases":1,
"pediatric":2,
"radioiodine therapy":1,
"Neoplasm":2,
"CA19-9":1,
"Prognostic factor":2,
"Conjunctival inclusion cyst":1,
"Orbital radioiodine uptake":1,
"Case reports":1,
"Head and neck neoplasms":1,
"Laryngeal neoplasms":1,
"Lipoma":1,
"Cushing’s disease":1,
"adrenocorticotropic hormone":1,
"canine":1,
"neuroendocrine tumor":3,
"hyperparathyroidism-jaw tumor syndrome":2,
"pediatric parathyroid carcinoma":1,
"rickets":1,
"genetic alteration":1,
"Cancer risk":1,
"H19":1,
"Polymorphism":2,
"rs217727":1,
"incidental findings":1,
"parathyroid neoplasm":1,
"radionuclide imaging":2,
"benign thyroidectomy":1,
"cervical thyroid remnant":1,
"Disease attribute":1,
"Lymphoma, non-Hodgkin":1,
"Bevacizumab":1,
"Esophageal metastasis":1,
"FOLFIRI":1,
"FOLFOX":1,
"illness perception":1,
"information":1,
"psychological distress":1,
"survivorship":2,
"Fluorine-18":1,
"Hexafluorophosphate":1,
"PET imaging":1,
"Radiofluorination":1,
"Sodium/iodide symporter":2,
"PET/CT imaging":1,
"computed tomography (CT)":1,
"myocardial perfusion imaging: PET":1,
"asymmetric distributions":1,
"asymmetric regression models":1,
"heavy-tailed distributions":1,
"left-censoring":1,
"Endobronchial ultrasound":1,
"non-small lung cancer":1,
"positron emission tomography":2,
"staging":1,
"MUC21":1,
"epithelioid mesothelioma":1,
"lung adenocarcinoma":1,
"CHC":1,
"HCC":2,
"dysfonction mitochondriale":1,
"déficit en nutriments":1,
"mitochondrial dysfunction":1,
"nutrient deficiency":1,
"oxidative stress":2,
"shikonin":1,
"shikonine":1,
"stress oxydant":1,
"8th AJCC/TNM staging system":1,
"outcome":3,
"poorly differentiated thyroid cancer":3,
"response to therapy":1,
"MDM2":1,
"haplotype":1,
"esophageal cancers":1,
"esophagectomy":1,
"lymphadenectomy":1,
"mediastinum":1,
"minimally invasive esophagectomy":1,
"Thyroid surgery":1,
"Transcutaneous laryngeal ultrasound":1,
"Vocal cord mobility":1,
"intraoperative nerve monitoring":2,
"nodal classification":1,
"recurrent laryngeal nerve paralysis":1,
"tumor classification":1,
"Machine learning":1,
"Thyrotropin":1,
"Ultrasonography, Doppler":1,
"Local ablative therapy":2,
"Metastatic thyroid cancer":3,
"Oligoprogression":2,
"Tyrosine kinase inhibitors":3,
"CREB1":1,
"CREBBP":1,
"H3K27Ac":1,
"LINC01857":1,
"promoter":1,
"telomerase":1,
"RNA-Seq":1,
"rearrangement":1,
"transcript fusion":1,
"MAPK pathway":1,
"Nrf2":1,
"Pinelliae rhizome":1,
"Xiaotan Sanjie decoction":1,
"111In-CP04":1,
"peptide radiopharmaceuticals":1,
"regulatory framework":1,
"theranostics nuclear medicine":1,
"FOXE1":2,
"Gli2":1,
"hedgehog":1,
"wnt/β-catenin":2,
"Margin":1,
"lateral neck metastasis":1,
"serum VEGF-C":1,
"aerodigestive tract":1,
"extrathyroidal extension":4,
"positive margins":1,
"Twist1":1,
"hepatocellular carcinoma (HCC)":1,
"propofol":1,
"miR-4458":1,
"suppressor of cytokine signaling 1":1,
"immune cell":1,
"multiplex immunohistochemistry":1,
"tumor microenvironment":3,
"AGREE":1,
"Evidence-based medicine":1,
"Fine needle aspiration":9,
"Guideline":2,
"imaging":2,
"reporting systems":1,
"Italy":3,
"overdiagnosis":1,
"Age":2,
"Gender":1,
"Metabolic syndrome":1,
"Thyroid volume":1,
"High-intensity focused ultrasound (HIFU)":1,
"Thermal ablation":1,
"PI3K/Akt pathway":1,
"TRIM26":1,
"tripartite motif family":1,
"tumor suppressor":1,
"LINC01433":1,
"MYC":1,
"miR-2116-3p":1,
"carbon nanoparticles":1,
"lymph node dissection":1,
"parathyroid":3,
"recurrent laryngeal nerve":4,
"ITGA3":1,
"miR-524-5p":1,
"PI3K/AKT signaling pathway":1,
"SPP1":1,
"microRNA-340":1,
"E-cadherin":2,
"Smad pathway":1,
"TGF-β":2,
"Turmeric, Curcumin":1,
"Vimentin":1,
"miR-183":1,
"phosphatidylinositol 3-kinase/AKT pathway":1,
"transcription factor 12":1,
"atrial fibrillation":1,
"cardiovascular events":1,
"EU-TIRADS":1,
"risk":1,
"microRNA classifier":2,
"molecular analysis":1,
"patient outcomes":1,
"Brazil":1,
"adolescents":1,
"childhood":3,
"population-based registries":1,
"rare tumors":1,
"mental health":1,
"psychiatric utilization":1,
"psycho-oncology":1,
"suicidal death":1,
"suicide":1,
"MCM3AP-AS1":1,
"Therapeutic target":1,
"Bethesda System for Reporting Thyroid Cytopathology (BSRTC)":1,
"atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS)":1,
"sonography":1,
"DNA-based screening":1,
"RET proto-oncogene":1,
"biochemical cure":1,
"model":1,
"preoperative":1,
"HIV and cancer":1,
"National Cancer Data Base":1,
"cancer patient mortality":1,
"cancer stage":1,
"health insurance and mortality":1,
"Cognitive impairment":1,
"TSH suppression therapy":1,
"MALDI mass spectrometry imaging":1,
"NIFTP":2,
"thyroid pathology":1,
"body composition":1,
"metabolic changes":1,
"resting energy expenditure":1,
"subclinical hyperthyroidism":1,
"TNBC":1,
"durvalumab":1,
"neoadjuvant":2,
"Anaplastic thyroid cancer (ATC)":1,
"HLA complex P5 (HCP5)":1,
"Viability":1,
"microRNA-128-3p":1,
"preferences":1,
"surveillance":1,
"well-being":1,
"Prospective cohort study":1,
"Randomized control trial":1,
"SELECT BC":1,
"Trial effect":1,
"Hyperinsulinemia":1,
"Thyroid peroxidase antibody":1,
"Gallic acid":1,
"LC-MS":1,
"Metal organic frameworks":1,
"Ribosylated metabolites":1,
"Selectivity":1,
"UiO-66":1,
"estrogen receptor":1,
"nomogram":3,
"Forkhead box E1":1,
"Migration and invasion":1,
"Platelet-derived growth factor":1,
"Microvessels":1,
"lncRNA AFAP1-AS1":1,
"lncRNA GAS8-AS1":1,
"FBXL19-AS1":1,
"LIN28A":1,
"Tumor progression":1,
"WDR66":1,
"American Thyroid Association":1,
"follicular thyroid cancer":2,
"Cell line":2,
"Characteristic":1,
"Dog":1,
"RET gene":1,
"thyroid carcinogenesis":1,
"thyroid stem cells":1,
"thyrospheres":1,
"tungsten":1,
"cancer therapeutics":1,
"p21-activated kinase":1,
"CXCL8":2,
"chemokine receptors":1,
"Jordan":1,
"hypothyroidism":4,
"thyroid dysfunction":1,
"Circulating tumor cells":1,
"Radioactive iodine-131 therapy":1,
"digital image analysis":1,
"noninvasive follicular thyroid neoplasm with papillary-like features (NIFTP)":1,
"quantitative":1,
"indeterminate thyroid nodules":1,
"molecular diagnostic testing":1,
"PD-1/PD-L1":1,
"cytokines":1,
"monoclonal antibodies":1,
"physical health":1,
"psychological health":1,
"VEGFR":1,
"adverse effect":1,
"drug toxicity":1,
"partial response":1,
"stable disease":1,
"STAT3":1,
"Self-renewal":1,
"lnc-DILC":1,
"Hypnotic":1,
"Sedative":1,
"polo-like kinase inhibitor":1,
"volasertib":1,
"well-differentiated thyroid cancer":1,
"Core needle biopsy":1,
"Pain":2,
"indications":1,
"morbidity":1,
"results":1,
"transoral endoscopic thyroidectomy vestibular approach":1,
"cancer cure":1,
"population-based cancer registries":1,
"dynamic risk assessment":1,
"H3K4me2":1,
"KDM1A":1,
"TIMP1":1,
"iodothyronine deiodinase 2":1,
"iopanoic acid":1,
"tumor angiogenesis":1,
"Watson for Oncology":1,
"artificial intelligence":1,
"iodine radioisotopes":2,
"bilateral surgery":1,
"neuromonitoring":1,
"vocal cord paralysis":1,
"death":1,
"survivors":1,
"worry":1,
"Atypia of undetermined significance/follicular lesion of undetermined significance":2,
"Nuclear groove":1,
"Nuclear overlapping":1,
"Nuclear scoring":1,
"molecular target therapy":1,
"tyrosine kinase inhibitor":4,
"androgen insensitivity syndromes (AIS)":1,
"androgen receptor":1,
"glucocorticoid receptor":1,
"hormone resistance":1,
"ligand-binding domain":1,
"multimerization":1,
"protein structure":1,
"Bethesda criteria":1,
"Thyroid ultrasound":3,
"Gene expression classifier":2,
"Gene mutations":1,
"Gene sequencing":1,
"Indeterminate thyroid nodule":1,
"Molecular testing":6,
"Mutational analysis":1,
"Extent of resection":1,
"Low-risk thyroid cancer":1,
"Thyroid lobectomy":1,
"Lymphadenopathy":1,
"Metastatic disease":1,
"Percutaneous ethanol ablation":1,
"Multiple endocrine neoplasia type 1":1,
"Pancreas":1,
"Pheochromocytoma":1,
"Surgical management":1,
"anoikis resistance":1,
"integrin alpha 6":1,
"miRNA-363-3p":1,
"ADPGK-AS1":1,
"OTX1":1,
"miR-3196":1,
"NOTCH1":1,
"benign thyroid nodule":2,
"follicular adenoma":1,
"17-OHP":1,
"17-hydroxyprogesterone":1,
"21- hydroxylase deficiency":1,
"21-OHD":1,
"NC-CAH polycystic ovary syndrome":1,
"PCOS":1,
"non-classic adrenal hyperplasia":1,
"RFA":1,
"autonomous nodule":1,
"cystic nodule":1,
"laser ablation":1,
"thermoablation":1,
"18F-FDG":1,
"Cachexia":1,
"Cardio-oncology":1,
"Glucose metabolism":1,
"Hodgkin's lymphoma":1,
"PET-CT":1,
"Capsaicin":1,
"Mesoporous silica":1,
"Photo-triggered":1,
"5-aza-2′-deoxycytidine":1,
"DNMT3A":1,
"Exome sequencing":1,
"expression":1,
"promoter mutation":2,
"prognostic marker":1,
"Fluorescence Microscopy":1,
"indeterminate":1,
"single-photon emission computed tomography":1,
"endocrine tumors":1,
"mechanism of action":1,
"metformin":2,
"preclinical evidence":1,
"MACC1":1,
"cell migration":1,
"malignant melanoma":1,
"miR-338-3p":2,
"dabrafenib":1,
"dedifferentiated":1,
"pembrolizumab":1,
"sarcomatoid":2,
"squamous":1,
"trametinib":1,
"undifferentiated":1,
"Mouse knockout":1,
"p21":1,
"p53":1,
"elastography":2,
"immune scores":1,
"MEN 2A":1,
"syndrome":1,
"DaVinci SP":1,
"Gasless transoral thyroidectomy":1,
"Vestibular approach":1,
"diabetes":2,
"MKL1":1,
"MMP2":1,
"Smad3":1,
"Ethacridine":1,
"apoptotic cell death":1,
"thyroid cancer cells":1,
"adenoma":2,
"bone metastasis":1,
"misdiagnosis":1,
"thoracic wall":1,
"Alcohol Consumption":1,
"Ear":1,
"Human Papilloma Virus":1,
"Larynx":2,
"Mouth":1,
"Nose":1,
"Pharynx":1,
"Radiation":2,
"Referral":1,
"Risk Factors":1,
"Smoking":1,
"B-RAF-V600E":1,
"CDKN1A":1,
"CDKN2B":1,
"EGR1":1,
"Glucocorticoid":1,
"Oncogene-induced senescence":1,
"DNA repair":1,
"SNPs":1,
"genetic markers":1,
"genetic susceptibility":1,
"CBX3":1,
"bioinformatics analysis":1,
"clinical significance":2,
"cardiothoracic surgery":1,
"dermatology":1,
"AJCC staging":1,
"capsular invasion":1,
"lymphovascular invasion":2,
"AKT3":1,
"NF-κB":1,
"miRNA":1,
"antiangiogenic treatment":1,
"embolization":1,
"patient safety":1,
"Diagnostic criteria":1,
"Painful goiter":1,
"Subacute thyroiditis":1,
"Gingiva squamous cell carcinoma":1,
"Marginal mandibulectomy":1,
"Oral squamous cell carcinoma":2,
"Nodular lymphocytic thyroiditis":1,
"Pre-cancerous factors":1,
"Subclinical hypothyroidism":1,
"TSH serum levels":1,
"cardiological comorbidity":1,
"Gene expression regulation":1,
"HDAC inhibitors":1,
"HDACs":1,
"RUNX2":1,
"ear, nose and throat/otolaryngology":1,
"advanced thyroid cancer":2,
"T reg cells":1,
"angiogenesis":1,
"chemokines":1,
"dendritic cells":1,
"lymphangiogenesis":1,
"macrophages":2,
"mast cells":2,
"neutrophils":2,
"IGF":1,
"IGF inhibitor":1,
"IGF-1R":1,
"acromegaly":3,
"ophthalmopathy":1,
"type 1 IGF receptor":1,
"ECG":1,
"Carcinoma, non-small cell lung":1,
"Carcinoma, squamous cell":1,
"Lung neoplasms":1,
"Neoplasms, multiple primary":1,
"131I therapy":1,
"18F-FDG PET/CT":1,
"mLN":1,
"C-reactive protein":1,
"gingival cyst":1,
"hyperplastic gingivitis":1,
"periodontitis":1,
"peripheral fibroma":1,
"procalcitonin":1,
"saliva":1,
"Keap1 (Kelch-like ECH-associated protein 1)":1,
"Nrf2 (nuclear factor erythroid 2-related factor 2)":1,
"antioxidant":1,
"goiter":4,
"CD15":1,
"cancer stem cell":1,
"Cancer Genome Atlas (TCGA)":1,
"gene expression and biological adhesion signature":1,
"thyroid papillary cancer":1,
"Parathyroid adenoma, MIBI scan":1,
"Chyle":1,
"Postoperative complications":1,
"Multifocal":1,
"Neoplasm invasiveness":1,
"Propensity score":1,
"Follicular thyroid adenoma":1,
"Follicular variant papillary thyroid carcinoma":1,
"Gene mutation":1,
"Next-generation sequencing":3,
"follicular thyroid neoplasm":1,
"guidelines":2,
"treatment recommendations":1,
"carcinogenesis":1,
"cancer immunology":1,
"Hürthle cell carcinoma":2,
"cell signaling":1,
"humans":1,
"near-homozygous genome":1,
"panitumumab":1,
"tumor":2,
"NOTCH":1,
"cancer-driven genes":1,
"germline mutations":1,
"malignant castration-resistant prostatic cells":1,
"mutational mechanism":1,
"neuroendocrine neoplasms":1,
"pancreatic NET":1,
"small bowel NET":1,
"small cell lung carcinoma":1,
"lobectomy":2,
"low-risk thyroid carcinoma":1,
"thyrotropin suppression treatment":1,
"microcarcinoma":1,
"recurrent carcinoma":1,
"disease characteristics":1,
"acoustic voice analysis":1,
"recurrent laryngealnerve":1,
"SWE":1,
"Cyclin D1":1,
"colorectal":1,
"Autotaxin":1,
"Lysophosphatidate":1,
"Aggressive carcinoma":1,
"Matched cohort":1,
"Outcomes":1,
"drugs and medicines":1,
"immunology":1,
"thyroiditis":1,
"DOTATATE":1,
"MIBG":1,
"PET/CT":1,
"Peptide receptor radionuclide therapy (PRRT)":1,
"Somatostatin receptor":1,
"Theranostic":2,
"Clinical characteristics":1,
"Delphian lymph node":1,
"Papillary thyroid cancer (PTC)":1,
"fine needle aspirates (FNAs)":1,
"preoperative diagnostics":1,
"fine needle aspiration (FNA)":2,
"follicular variant":1,
"non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"frozen sections (FS)":1,
"CASTLE":3,
"PD-L1":3,
"checkpoint inhibitor":1,
"extrathyroidal":1,
"parotid":1,
"thymus-like":1,
"Cervical lymphectomy":1,
"Lymph node metastases":3,
"One-step nucleic acid amplification (OSNA)":1,
"Real-time PCR":1,
"autofluorescence":1,
"indocyanine green":1,
"near-infrared":1,
"parathyroid gland":1,
"Nuclear power workers":1,
"AKT pathway":1,
"﻿miRNA-15a":1,
"Wnt5a":1,
"microRNA-26a-5p":1,
"neutrophil-to-lymphocyte ratio":1,
"survival analysis":2,
"young patient":1,
"Hashimoto’s thyroiditis (HT)":1,
"anti-thyroid peroxidase antibody (TPOAb)":1,
"Intracranial mature teratoma":1,
"Malignant transformation":2,
"SEER":1,
"ultrasonography (US)":1,
"Sentinel lymph node biopsy (SLNB)":1,
"carbon nanoparticles (CNs)":1,
"second surgery":1,
"carcinosarcoma":1,
"Ewing sarcoma":1,
"laryngeal cancer":2,
"metastases":1,
"pnets":1,
"ERK":1,
"tumor necrosis factor α-induced protein 8-like-1 (TIPE1)":1,
"Deep convolutional neural network":1,
"cytological images":1,
"liquid-based cytology":1,
"hyroid nodule Thyroid isotope scan":1,
"HIF1α":2,
"hypoxia":2,
"immune checkpoint antibody":1,
"skin toxicities":1,
"autoimmune encephalitis":1,
"fluorodeoxy glucose positron emission tomography (fdg-pet)":1,
"nmda encephalitis":1,
"seizures":1,
"hematologic tests":1,
"immune system":1,
"lymphocytes":1,
"CITED1":1,
"PDCD4":1,
"BRMS1":1,
"CX43":1,
"MicroRNA-182":1,
"prognostic value":1,
"NTRK fusions":1,
"ancillary testing":1,
"hepatotoxicity":1,
"metastatic renal cell carcinoma":1,
"nivolumab":1,
"pazopanib":1,
"Resveratrol":1,
"chemopreventive agent":1,
"ER":1,
"MED12":1,
"NAB2-STAT6":1,
"fibroadenoma":1,
"pulmonary adenofibroma":1,
"solitary fibrous tumour":1,
"HER2":1,
"HER4":1,
"L-Dopa decarboxylase":1,
"TAAR1 (trace amine-associated receptor 1)":1,
"Trace amines":1,
"4D-computed tomography":1,
"glottic cancer":1,
"larynx motion":1,
"magnetic resonance imaging":1,
"volumetric modulated arc radiotherapy":1,
"solid tumor":2,
"tumor-infiltrating tryptase+ mast cells":1,
"unfavorable outcome":1,
"PKM1":2,
"endometrial cancer":1,
"immunostaining":1,
"pyruvate kinase":1,
"receiver operating characteristic curve":1,
"sensitivity":1,
"specificity":1,
"Cofilin 1":1,
"LIM domain kinase 1":1,
"MiR-519d-3p":1,
"Adrenal lymphomas":1,
"Pituitary hematological neoplasia":1,
"Thyroid lymphomas":1,
"Cushing disease":1,
"adrenocorticotrophin (ACTH)":1,
"anterior pituitary":1,
"clinical chemistry":1,
"growth hormone (GH)":1,
"prolactin":1,
"secretory tumors":1,
"thyroid-stimulating hormone (TSH)":1,
"camera-based neck uptake":1,
"thyroid uptake probe":1,
"Ailanthone (AIL)":1,
"MicroRNA-148a":1,
"Epithelial–mesenchymal transition":1,
"PCGEM1":1,
"SNAI1":1,
"adolescent/young adult":1,
"employment":1,
"finances":1,
"DCE-MRI":1,
"preoperative prediction":1,
"radiomics":3,
"Core-needle biopsy":1,
"Lymphatic vessel invasion":1,
"Twist":1,
"VEGF-C":1,
"alpha therapy":1,
"ascorbic acid":1,
"astatine":1,
"sodium iodide symporter":1,
"Treatment outcome":1,
"Multislice computed tomography":1,
"Disease risk":1,
"Healthy longevity":1,
"Single nucleotide polymorphism":1,
"Somatic mutation":1,
"Triple negative breast cancer":1,
"caspase 9":1,
"lncRNA POU3F3":1,
"BRAF V600E antibody (clone VE1)":1,
"cell block":1,
"Brown tumors":1,
"Parathyroid carcinoma":1,
"PPP2CA":1,
"miR-650":1,
"clear cell variant":1,
"Sendai virus":1,
"oncolytic virus":1,
"urokinase-type plasminogen activator":1,
"virotherapy":1,
"TEP":1,
"TKI":1,
"biologics":1,
"laryngectomy":1,
"prosthesis":1,
"tracheoesophageal fistula":1,
"wound healing":1,
"PPAR gamma":1,
"fine needle":2,
"genes":1,
"retrospective studies":1,
"high tumor burden":1,
"multitarget kinase inhibitors":1,
"radioiodine-refractory differentiated thyroid cancer":1,
"tumor growth parameters":1,
"EWSR1":1,
"NR4A3":1,
"TAF15":1,
"axon guidance":1,
"extraskeletal myxoid chondrosarcomas":1,
"sarcoma":1,
"transcriptional profile":1,
"RCC":1,
"TLFCK":1,
"thyroid-like follicular carcinoma of the kidney":1,
"continuous intraoperative nerve monitoring":1,
"laryngeal adductor reflex":1,
"vagal schwannoma":1,
"vagus nerve":1,
"the Bethesda System for Reporting Thyroid Cytopathology":1,
"Go terms":1,
"differential expression networks":1,
"ego genes":1,
"gastric cancer (GC)":1,
"EMT":2,
"IQGAP1":1,
"VEGF-A":1,
"timing":1,
"classification":2,
"cytopathology":3,
"Psammoma bodies":1,
"papillary carcinoma lung":1,
"pericardial effusion":1,
"malignant":1,
"teratoma":1,
"Multidisciplinary therapies":1,
"Spinal metastases":1,
"Granular cell tumor":1,
"Pituicytoma":1,
"Pituitary":1,
"Sellar tumors":1,
"Spindle cell oncocytoma":1,
"TTF-1":1,
"PROMIS":1,
"physical function":1,
"Destructive thyroiditis":1,
"LAMC2":1,
"MYO1G":1,
"quantitative proteomics":1,
"Spatial heterogeneity":1,
"endoscopic":1,
"radioiodine treatment":1,
"whole-body scan":1,
"Fractures":1,
"Osteoporosis":1,
"Veterans":1,
"ACR TI-RADS":1,
"thyroid calcifications":1,
"Cholesterol metabolism":1,
"Dendrogenin A":1,
"Tumor-suppressor":1,
"phase 2":1,
"radioactive iodine (RAI)-refractory":1,
"vascular endothelial growth factor receptor (VEGF) Trap":1,
"Glioma growth":1,
"LINC00689":1,
"Autoimmunity":1,
"Graves' disease":1,
"IFNγ":1,
"PD-1":2,
"PD-L2":1,
"T-Lymphocytes":1,
"Tolerances":1,
"Hurthle cell neoplasm":1,
"cold nodule":1,
"hot nodule":1,
"warm nodule":1,
"Colorectal cancer –reproductive outcomes":1,
"Drinking water":1,
"Economic analysis":1,
"Nitrate":1,
"head and neck squamous cell carcinoma metastasis":1,
"metastasis to thyroid":1,
"secondary squamous cell carcinoma of thyroid":1,
"ltrasound":1,
"Fusion imaging":1,
"Iodine-124":1,
"Antiangiogenic":1,
"Molecular biology":1,
"Network":1,
"Radioiodine-refractory differentiated thyroid carcinoma":1,
"TUTHYREF":1,
"Target therapy":2,
"Bethesda classification":1,
"Bethesda system III/IV":1,
"US-FNA":1,
"ultrasound characteristics":1,
"EZ-Blocker":1,
"Intraoperative monitoring":1,
"One-lung ventilation":1,
"Thoracic surgery":1,
"Ectopic papillary carcinoma":1,
"Floor of mouth":1,
"Reconstruction":1,
"Tensor fascia lata":1,
"Thyroglossal duct tract":1,
"TTF1":2,
"carcinoma showing thymic-like differentiation":1,
"esophageal resection":1,
"suprahyoid release":1,
"tracheal resection":1,
"Antitumor activity":1,
"Released polysaccharides (RPS)":1,
"Sulfated polymer":1,
"Synechocystis":1,
"FBXL19":1,
"HECW1":1,
"different cell types":1,
"ubiquitination":1,
"esophageal reconstruction":1,
"free bipaddled posterior tibial artery perforator flap":1,
"simultaneous reconstruction":1,
"FNA":2,
"risk of malignancy":2,
"thyroid cytology":1,
"Bladder":1,
"Carcinome urothélial":1,
"Cytologie urinaire":1,
"Urinary cytology":1,
"Urothelial carcinoma":1,
"Vessie":1,
"PD0325901":1,
"PLX51107":1,
"bromodomain and extraterminal protein inhibitor":1,
"Radiofrequency ablation":1,
"Isoforms":1,
"Normal thyroid":1,
"Gene Expression Omnibus":1,
"Weighted gene co-expression network analysis":1,
"C cell hyperplasia":1,
"C cells":1,
"RAI refractory":1,
"Real life":1,
"Diagnostic accuracy":1,
"CCND1":1,
"NR2F1-AS1":1,
"miRNA-338-3P":1,
"Follicular neoplasm/suspicious for follicular neoplasm":1,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"Fukushima":1,
"Japanese Black":1,
"cattle":1,
"molecular profiling":1,
"radioactive iodine refractory":1,
"neonatal outcomes":1,
"pregnancy":3,
"pregnancy outcomes":1,
"Pancreatic cancer":2,
"Distant metastases":1,
"Radioiodine refractory":1,
"Unusual metastases":1,
"biochemical recurrence/persistent disease":1,
"clinicopathological factor":1,
"programmed death-ligand 1":1,
"structural recurrence":1,
"bisulfite-pyrosequencing":1,
"diagnostic markers":1,
"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"Cadmium":1,
"Cd/Se ratio":1,
"Trace metals (endocrine disrupters)":1,
"Lipid metabolism":1,
"Cell migration and invasion":1,
"Cofilin":1,
"Cytoskeleton":1,
"RPI-1":1,
"ablation":1,
"contrast media":1,
"radiofrequency":1,
"GLIS3":1,
"PAX-GLIS3":1,
"fusion":1,
"hyalinizing trabecular tumor (HTT)":1,
"controlled drug release":1,
"nanomedicines":1,
"photothermal therapy":1,
"refractory thyroid cancer":1,
"theranostics":1,
"polymerase chain reaction":1,
"angioinvasion":1,
"widely invasive":1,
"Adénome thyréotrope":1,
"Hyperthyroïdie":1,
"Pit-1":1,
"Pituitary tumor":1,
"Somatostatin analogs":1,
"TSH adenoma":1,
"TSH-secreting tumor":1,
"Tumeur hypophysaire":1,
"Tumeur thyréotrope":1,
"Incidence du cancer thyroïdien":1,
"Incidence of thyroid cancer":1,
"Microcarcinome papillaire":1,
"Micropapillary carcinoma":1,
"Registre des cancers thyroïdiens":1,
"Standardized incidence rate":1,
"Taux incidence standardisée":1,
"Thyroid cancer registry":1,
"Mature cystic teratoma":1,
"Bethesda III/IV nodule":1,
"cost-effectiveness":1,
"diagnostic lobectomy":1,
"MEK1 mutations":1,
"RAS-like":1,
"ARHI":1,
"imprinted gene":1,
"CTLA-4":1,
"Forecasting":1,
"5-hydoxymethylcytosine":1,
"biological marker":1,
"epigenetics":1,
"case parameters":1,
"deleted in malignant brain tumors":1,
"phosphoinositide-dependent protein kinase 1":1,
"two-dimensional ultrasound":1,
"polycystic kidney and hepatic disease 1-like 1":1,
"Mts1":1,
"endocrine cancer":1,
"(131)I-NaI activity":1,
"Dosimetry":1,
"Pharmacokinetics":1,
"Thyroid remnants":1,
"GLIS Krüppel-like zinc finger proteins":1,
"chromosomal translocation":1,
"leukemogenesis":1,
"oncogenesis":1,
"transcription":1,
"Growth hormone secreting adenomas":1,
"RET/PTC":1,
"driver mutation":1,
"molecular signature":1,
"FAPI":1,
"PSMA":1,
"neurotensin":1,
"radionuclide therapy":1,
"BMS-986253":1,
"HuMax-IL8":1,
"Immune assays":1,
"Interleukin-8 (IL-8)":1,
"Metastatic cancer":1,
"Monoclonal antibody":1,
"American Joint Committee on Cancer (AJCC)":1,
"Differentiated thyroid cancer (DTC)":1,
"Fine needle aspiration cytology (FNAC)":1,
"TSH levels":1,
"Thyroid antibody levels":1,
"vitamin D level":1,
"gene panel":1,
"genetic testing of thyroid nodules":1,
"génpanel":1,
"new generation sequencing":1,
"pajzsmirigydaganatok":1,
"pajzsmirigygöbök genetikai vizsgálata":1,
"thyroid tumors":1,
"újgenerációs szekvenálás":1,
"Artificial intelligence in ultrasound":1,
"breast lesion":1,
"deep learning in ultrasound":1,
"liver lesion":1,
"ACTH independent hypercortisolism":1,
"parathyroid cancer":1,
"Parathyroid adenoma":1,
"immune cells":1,
"Korea National Health and Nutrition Examination Survey":1,
"cancer survivors":1,
"hand strength":1,
"VUS":1,
"genetic screening":1,
"exosomes":1,
"heat shock proteins (Hsp)":1,
"molecular chaperones":1,
"PBX3":1,
"miR-129-5p":1,
"MALDI-MSI":1,
"health services administration &amp":1,
"management":1,
"primary care":1,
"public health":1,
"radiology &amp":1,
"ACTN4":1,
"miR-192-5p":1,
"Malignant struma ovarii":1,
"PPARgamma":1,
"mTOR inhibitors":1,
"molecular alterations":1,
"radioactive iodine resistance":1,
"gene rearrangements":1,
"targeted cancer therapy":1,
"Diagnostic techniques and procedures":1,
"thyroid cancers":1,
"Golgi phosphoprotein 3":1,
"Neoplasm metastasis":1,
"aerobic glycolysis":1,
"esophageal cancer cell":1,
"pyruvate kinase muscle isozyme 2 (PKM2)":1,
"vacuolar H+-ATPase subunit V0C":1,
"Component analysis":1,
"Kazakhstan":1,
"nomograms":1,
"tumor staging":1,
"Contrast enhanced CT scan":1,
"TNM staging":1,
"Central compartment lymph node dissection":1,
"Central compartment lymph nodes":1,
"Histopathological examination":1,
"Well-differentiated thyroid malignancy":1,
"FT-UMP":1,
"clinical screening":1,
"NF-kB":1,
"cell cycle":1,
"triple-negative breast cancer cells":1,
"Isotopes":1,
"Sodium-iodide symporter":1,
"HMGA2":1,
"ZFAS1":1,
"miR-590-3p":1,
"lymphocyte-to-monocyte ratio":1,
"DNM3":1,
"linc01278":1,
"Atypia of undetermined significance":1,
"follicular lesion of undetermined significance":1,
"AURKB":1,
"GESA":1,
"TCGA database":1,
"ccRCC":1,
"machine-learning":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"support vector machine":1,
"Gingiva":1,
"Lymph node":2,
"Merkel cell carcinoma":1,
"head and neck":1,
"neck lymph node dissection":1,
"ACTH syndrome":1,
"Ectopic":1,
"LT4 treatment":1,
"ergodicity":1,
"intra-class correlation":1,
"response heterogeneity":1,
"setpoint":1,
"thyroid homeostasis":1,
"SEER database":2,
"Columnar cell":1,
"mortality":1,
"propensity score matching analysis":1,
"central lymph node metastasis":1,
"BRAF mutation":1,
"thyroid stimulating hormone":2,
"Chordoma":1,
"Notochord":1,
"SMARCB1 Protein":1,
"fineneedleaspirationcytology":1,
"papillarythyroidcarcinoma":1,
"prophylacticnodedissection":1,
"surgeon-performedultrasound":1,
"hypocalcemia":1,
"hypoparathyroidism":1,
"CRP":1,
"ferritin":1,
"inflammatorymarkers":1,
"Gd3+":1,
"MR molecular imaging":1,
"SHP2":1,
"nanoparticles":1,
"thyroid tumor":1,
"SDHAF2, thyroid":1,
"carotid body":1,
"neoplasia":1,
"paraganglioma":1,
"TMTP1":1,
"cervical cancer":1,
"micelles":1,
"near-infrared imaging":1,
"sentinel lymph node":1,
"cancer of unknown primary":1,
"cancer of unknown primary site":1,
"metastatic cancer of unknown primary site":1,
"primary cancer of unknown origin":1,
"Hashimoto's thyroiditis":1,
"thyroid hormones":1,
"Deep convolutional neural network (DCNN)":1,
"Inception-ResNet-v2":1,
"VGG-19":1,
"diagnostic efficiency":1,
"central lymph node dissection (central LND)":1,
"central lymph node metastasis (LNM)":1,
"Adenoid cystic carcinoma":1,
"laryngeal tumor":1,
"minor salivary gland cancer":1,
"GSK1059615":1,
"Glucose restriction":1,
"MCF-7":1,
"MDA-MB 231":1,
"BRAF V600E gene":1,
"Blood cell count":1,
"Mean platelet volume":1,
"YN968D1":1,
"antiangiogenesis drug":1,
"cervix carcinoma":1,
"safety":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2019年第3季度论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
